Guest guest Posted April 23, 2008 Report Share Posted April 23, 2008 BISPHENOL A Yeast testing gave rise to health concerns Accidental discovery in the early 1990s led to efforts to test the chemical's safety MARTIN MITTELSTAEDT, ENVIRONMENT REPORTER April 17, 2008 Like many of the most fascinating discoveries in science, the possibility that bisphenol A might present a health problem emerged completely by accident. In the early 1990s, researchers at Stanford University School of Medicine in California were investigating yeast to see whether it had a primitive estrogen receptor, and were finding something wonky going on in their laboratory. When they ran their yeast experiments, they noted that some unknown substance was acting just like estrogen - a main female hormone in humans - and was interfering with their tests. They eventually published a paper in the journal Endocrinology in 1993 alerting other researchers that a synthetic chemical able to mimic estrogen was leaching into water they were using - water that had been stored in polycarbonate plastic flasks subjected to autoclaving, or high-temperature heating. Using nuclear magnetic resonance spectroscopy and other sophisticated techniques, they identified the substance as bisphenol A, or BPA. Although they found that BPA was far less potent than natural female hormones in their experiments, the scientists issued a warning and a challenge to other researchers. " Our findings raise the possibility that unsuspected estrogenic activity in the form of BPA may have an impact on experiments employing media autoclaved in polycarbonate flasks. It remains to be determined whether BPA derived from consumer products manufactured from polycarbonate could significantly contribute to the pool of estrogenic substances in the environment, " said the paper, whose lead author was Feldman, a Stanford medicine professor. This serendipitous discovery triggered the start of efforts to test the safety of BPA. Fifteen years later, it is having stunning resonance in Canada, as retailers rush to remove polycarbonate plastic water bottles from their shelves and many parents revert to using glass again for baby bottles. Canada is poised to become the first country to take strong action on BPA, by placing it on the country's list of toxic substances. Such a designation would allow Health Canada or Environment Canada to take actions to control use of the chemical for either human-health reasons or to protect the environment. Bisphenol A is one of the most widely used synthetic substances in the world, with industry able to make about three billion kilograms a year. There are no domestic BPA manufacturing plants; Canadian companies that use the chemical import it. Derived from petroleum, BPA was first identified around 1900 and tested in the 1930s during the initial search for estrogen-like drugs. The chemical would likely have languished in obscurity had it not been for a discovery in the 1950s made independently by chemists in the United States and Germany: that BPA could be used as the starting material for polycarbonate, a remarkably durable, lightweight plastic that resembles glass. Although BPA is now in hundreds of products, from the plastic lenses of glasses to the coverings of compact discs and DVDs, the uses that have caused controversy are those, such as plastic baby bottles or the lacquer linings inside tin cans, that allow it to come into contact with food and beverages. Under normal conditions, such as the heating of a tin can to sterilize its contents, or high-temperature washing of plastic, trace amounts of BPA are able to leach into the foods or drinks, and ultimately into the people who consume them. The amount leaking from containers is vanishingly small, typically in the low parts per billion. One part per billion is equivalent to only one second of elapsed time over a 32-year period, and until scientists began investigating hormones and chemicals that act like them, this was thought to be such a minute quantity that it couldn't possibly have any biological effect. However, some hormones, such as estrogen, are active in far lower, parts per trillion, concentrations, and dozens of studies by independent researchers have found that low doses of BPA have dramatic impacts in animal experiments. These studies have shown the chemical has effects such as increasing the number of mammary ducts in rodents, as well as boosting the size of prostates, particularly for trace exposures during fetal development and early in life. These findings, which began emerging in the late 1990s, prompted worries the chemical could be linked to conditions such as cancer, the earlier onset of puberty in girls, declining sperm counts and other problems connected to hormone imbalances. The Dose Debate There has been worldwide interest in bisphenol A, but to date no major regulator has taken strong action against the chemical. The U.S. Food and Drug Administration has approved the use of BPA, as has the European Food Safety Authority. Both have based their decisions mainly on research funded by the chemical industry that has found bisphenol A doesn't cause health problems in animals at low doses, although it does at high exposures. Contradicting these findings are a large number of studies, conducted by independent scientists, that have found the chemical affects the prostate, the mammary gland and brain development at tiny doses similar to what humans are exposed to through consumer products, particularly at key points during fetal development. About 90 per cent of studies by independent scientists have detected some adverse effects at low doses, according to a running tally compiled by Frederick vom Saal, a researcher at the University of Missouri. Critics of BPA say one of the difficulties figuring out what to do with the chemical is that hormonally active substances such as bisphenol A, which mimics estrogen, present a special challenge for scientists used to traditional toxicology studies. The mantra among toxicologists is that " the dose makes the poison. " In other words, the more of a dangerous substance people or animals are exposed to, the more adverse effects will be observed - the way a two-pack-a-day smoker faces more risk of lung cancer than a one-pack-a-day user. Under this principle, extremely low doses are assumed to pose very low or non-existent risks. But hormonally active chemicals don't follow this commonsense rule and exert their influence at the minute amounts typical of natural hormones. Paradoxically, hormones can have more pronounced effects at low doses than at high ones. " Why did traditional toxicology miss the effects of bisphenol A for so long? It turns out it's because ... it follows non-traditional dose response curves, " said Pete Myers of Environmental Health Sciences, a U.S.-based advocacy group. Mittelstaedt http://www.theglobeandmail.com/servlet/story/LAC.20080417.BPAORIGINS17/TPStory/N\ ational Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.